SCHEMBL456278

SCHEMBL456278

C/C=[C]/CCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5245514 1.00
SCHEMBL4465892 1.00
SCHEMBL27902632 0.97 TSHR (0.44)
SCHEMBL7792866 0.97
SCHEMBL17479245 0.97 TSHR (0.44)
SCHEMBL18984779 0.97 TSHR (0.44)
SCHEMBL7792864 0.97
SCHEMBL17479248 0.97 TSHR (0.44)
SCHEMBL6401134 0.91
SCHEMBL6401130 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112654625-A Heterocyclic and heteroaryl compounds for the treatment of huntington's disease PTC医疗公司 2021-04-13 CN claimed
WO-2016192074-A1 BTK INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-12-08 WO claimed
EP-1150715-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING NICOTINE OR A LIGAND OF NICOTINE RECEPTORS AND A MONAMINE OXYDASE INHIBITOR AND THEIR USE FOR TREATING TOBACCO WITHDRAWAL SYMPTOMS SANOFI-SYNTHELABO (FR) 2001-11-07 EP claimed
WO-2000045846-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING NICOTINE OR A LIGAND OF NICOTINE RECEPTORS AND A MONAMINE OXYDASE INHIBITOR AND THEIR USE FOR TREATING TOBACCO WITHDRAWAL SYMPTOMS SANOFI-SYNTHELABO (FR) 2000-08-10 WO claimed
US-5736579-A ANTIARTHRITIC, ANTIPYRETIC AND ANALGESIC AGENTS G.D. SEARLE & CO. (US) 1998-04-07 US claimed
EP-0315518-B1 Cephalosporins having in position 3 a substituted vinyl radical, their process for preparation, their application as medicaments, compositions containing them and intermediates ROUSSEL UCLAF (FR) 1994-02-16 EP claimed
EP-0315518-A1 Cephalosporins having in position 3 a substituted vinyl radical, their process for preparation, their application as medicaments, compositions containing them and intermediates ROUSSEL-UCLAF (FR) 1989-05-10 EP claimed
CN-117304183-A Five-membered and six-membered nitrogen-containing compound, intermediate thereof, preparation method and application 杭州圣域生物医药科技有限公司 2023-12-29 CN disclosed
CN-115894497-A Imidazopyrimidine compounds, and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2023-04-04 CN disclosed
CN-107454902-B Chromene derivatives as phosphoinositide 3-kinase inhibitors 奇斯药制品公司 2020-09-15 CN disclosed
US-20190090520-A1 REDUCED SODIUM FOOD PRODUCTS GEN MILLS INC (US) 2019-03-28 US disclosed
US-10159268-B2 Reduced sodium food products GENERAL MILLS, INC. (US) 2018-12-25 US disclosed
WO-2016192074-A1 BTK INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-12-08 WO disclosed
EP-0282365-B1 1-DETHIA-2-THIA-CEPHALOSPORANIC-ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS THERAPEUTIC AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1993-05-12 EP disclosed
EP-0214029-B1 1-DETHIA-2-THIA CEPHALOSPORANIC-ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS THERAPEUTIC AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1992-03-25 EP disclosed
EP-0462009-A1 Cephalosporins having in position 3 a propenyl radical substituted by a quaternary ammonium, their process for preparation, their use as medicaments, compositions containing them and intermediates ROUSSEL UCLAF (FR) 1991-12-18 EP disclosed
EP-0315518-A1 Cephalosporins having in position 3 a substituted vinyl radical, their process for preparation, their application as medicaments, compositions containing them and intermediates ROUSSEL-UCLAF (FR) 1989-05-10 EP disclosed
EP-0282365-A1 1-Dethia-2-thia-cephalosporanic-acid derivatives, process for their preparation, their use as therapeutic agents and pharmaceutical compositions containing them ROUSSEL-UCLAF (FR) 1988-09-14 EP disclosed
EP-0214029-A1 1-Dethia-2-thia cephalosporanic-acid derivatives, process for their preparation, their use as therapeutic agents and pharmaceutical compositions containing them ROUSSEL-UCLAF (FR) 1987-03-11 EP disclosed
EP-0031305-A2 Compositions containing acrylate and their polymerisation CIBA-GEIGY AG (CH) 1981-07-01 EP disclosed